| Report ID |
121390 |
| Drug Identification Number |
02421089 |
| Brand name |
ZALTRAP |
| Common or Proper name |
AFLIBERCEPT solution |
| Company Name |
SANOFI-AVENTIS CANADA INC |
| Market Status |
CANCELLED POST MARKET |
| Active Ingredient(s) |
AFLIBERCEPT |
| Strength(s) |
200MG |
| Dosage form(s) |
SOLUTION |
| Route of administration |
INTRAVENOUS |
| Packaging size |
8mL vial |
| ATC code |
L01XX |
| ATC description |
OTHER ANTINEOPLASTIC AGENTS |
| Reason for discontinuation |
Business reasons |
| Anticipated discontinuation date |
|
| Actual discontinuation date |
2020-07-13 |
| Remaining supply date |
2016-07-31 |
| Discontinuation status |
Discontinued |
| Discontinuation decision reversal |
No |
| Information on remaining supply |
|
| Company comments |
last lot 3F007A, expiry 2016-07-31 |
| Health Canada comments |
|
| Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |
